Cancer Care Ontario | Action Cancer Ontario

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

16 Results

Guidelines and Advice

Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus

Status: Education and Information
ID: 2-12
Version: 2

Oct 2013

Guidelines and Advice

Adjuvant Radiotherapy Post-Prostatectomy in T3 or Margin Positive Prostate Cancer

Status: Archived
ID: 3-17
Version: 3

Dec 1969

Guidelines and Advice

Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer

Status: Education and Information
ID: 7-12 Version 2
Version: 2

Dec 1969

Guidelines and Advice

Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma

Status: Archived
ID: 2-23
Version: 2-23 Version 2

Oct 2015

Guidelines and Advice

Adjuvant Radiotherapy in Women with Stage I Endometrial Cancer

Status: Archived
ID: 4-10

Dec 1969

Guidelines and Advice

Accelerated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Status: Archived
ID: 5-6c

Nov 2000

Guidelines and Advice

Contouring Nomenclature - Recommendation Report (Head and Neck Cancer)

Status: Current
ID: GL-C50-12

Dec 1969

Guidelines and Advice

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Status: Current
ID: GL-7-A-2016-3

Dec 1969

Guidelines and Advice

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Status: Current
ID: GL END 9-10
Version: 2

Dec 1969

Guidelines and Advice

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Status: In-Review
ID: 3-22
Version: N/A

Dec 1969

Guidelines and Advice

Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario

Status: Current
ID: GL 21-6

Dec 1969

Guidelines and Advice

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Status: Current
ID: GL-END-C50-35

Dec 1969

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus

Adjuvant Radiotherapy Post-Prostatectomy in T3 or Margin Positive Prostate Cancer

Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer

Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma

Adjuvant Radiotherapy in Women with Stage I Endometrial Cancer

Accelerated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Contouring Nomenclature - Recommendation Report (Head and Neck Cancer)

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Pages